|
1
|
Chen J, Gu D, Chen CS, Wu X, Hamm LL,
Muntner P, Batuman V, Lee CH, Whelton PK and He J: Association
between the metabolic syndrome and chronic kidney disease in
Chinese adults. Nephrol Dial Transplant. 22:1100–1106. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cruz MC, Andrade C, Urrutia M, Draibe S,
Nogueira-Martins LA and Sesso Rde C: Quality of life in patients
with chronic kidney disease. Clinics (Sao Paulo). 66:991–995. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jepson RE: Current understanding of the
pathogenesis of progressive chronic kidney disease in cats. Vet
Clin North Am Small Anim Pract. 46:1015–1048. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rabbani N and Thornalley PJ: Advanced
glycation end products in the pathogenesis of chronic kidney
disease. Kidney Int. 93:803–813. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Arnold R, Issar T, Krishnan AV and Pussell
BA: Neurological complications in chronic kidney disease. JRSM
Cardiovasc Dis. 5:20480040166776872016.PubMed/NCBI
|
|
6
|
Huan L, Yuezhong L, Chao W and HaiTao T:
The urine albumin-to-creatinine ratio is a reliable indicator for
evaluating complications of chronic kidney disease and progression
in IgA nephropathy in China. Clinics (Sao Paulo). 71:243–250. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lips P, Goldsmith D and de Jongh R:
Vitamin D and osteoporosis in chronic kidney disease. J Nephrol.
30:671–675. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shigematsu T, Muraoka R, Sugimoto T and
Nishizawa Y: Risedronate therapy in patients with mild-to-moderate
chronic kidney disease with osteoporosis: Post-hoc analysis of data
from the risedronate phase III clinical trials. BMC Nephrol.
18:662017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Marciniak C, Gabet J, Lee J, Ma M, Brander
K and Wysocki N: Osteoporosis in adults with cerebral palsy:
Feasibility of DXA screening and risk factors for low bone density.
Osteoporos Int. 27:1477–1484. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ward C, Contino K, Patel A, Mbei EE, Roy
S, Hunter K and Gandhi S: The association of serum
25-Hydroxyvitamin D status in patients with osteoarthritis in the
primary care office. N Am J Med Sci. 8:47–55. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pongpirul W, Pongpirul K, Ananworanich J,
Klinbuayaem V, Avihingsanon A and Prasithsirikul W: Chronic kidney
disease incidence and survival of Thai HIV-infected patients. AIDS.
32:393–398. 2018.PubMed/NCBI
|
|
12
|
Michishita R, Matsuda T, Kawakami S,
Tanaka S, Kiyonaga A, Tanaka H, Morito N and Higaki Y: The
association between changes in lifestyle behaviors and the
incidence of chronic kidney disease (CKD) in middle-aged and older
men. J Epidemiol. 27:389–397. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kochi M, Kohagura K, Shiohira Y, Iseki K
and Ohya Y: Chronic kidney disease, inflammation, and
cardiovascular disease risk in rheumatoid arthritis. J Cardiol.
71:277–283. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li ZY, Zheng Y, Chen Y, Pan M, Zheng SB,
Huang W, Zhou ZH and Ye HY: Brazilin ameliorates diabetic
nephropathy and inflammation in db/db mice. Inflammation.
40:1365–1374. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Batchu SN, Hughson A, Gerloff J, Fowell DJ
and Korshunov VA: Role of Axl in early kidney inflammation and
progression of salt-dependent hypertension. Hypertension.
62:302–309. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Garcia-Bello JA, Gómez-Díaz RA,
Contreras-Rodríguez A, Talavera JO, Mondragón-González R,
Sanchez-Barbosa L, Diaz-Flores M, Valladares-Salgado A, Gallardo
JM, Aguilar-Kitsu A, et al: Carotid intima media thickness,
oxidative stress, and inflammation in children with chronic kidney
disease. Pediatr Nephrol. 29:273–281. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lim GB: Arrhythmias: IL-6 and risk of
atrial fibrillation in chronic kidney disease. Nat Rev Cardiol.
13:1832016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xun C and Zhao Y: Potential role of
soluble TNF-α receptors in diagnosis of patients with chronic
kidney disease. Ann Clin Lab Sci. 47:310–314. 2017.PubMed/NCBI
|
|
19
|
Peltonen S, Biancari F, Lindgren L,
Mäkisalo H, Honkanen E and Lepäntalo M: Outcome of infrainguinal
bypass surgery for critical leg ischaemia in patients with chronic
renal failure. Eur J Vasc Endovasc Surg. 15:122–127. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kumar S, Mavuduru RS and Sharma V:
Pan-ureteric transitional cell carcinoma in a patient of autosomal
dominant polycystic kidney disease with chronic renal failure. NDT
Plus. 2:76–77. 2009.PubMed/NCBI
|
|
21
|
Levin A, Le Barbier M, Er L, Andress D,
Sigrist MK and Djurdjev O: Incident isolated 1,25(OH)(2)D(3)
deficiency is more common than 25(OH)D deficiency in CKD. J
Nephrol. 25:204–210. 2012. View Article : Google Scholar : PubMed/NCBI
|
